Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

This description is about a grant relating to research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia. The grant comes under the R01 Clinical Trial (which is optional), and is designed to fund studies that increase our understanding of mechanisms linked to NPS in individuals with Alzheimer's disease or Alzheimer's disease-related dementias.

The ultimate goal of this Funding Opportunity Announcement (FOA) is to expand the scientific knowledge base regarding biobehavioral and neurobiological pathways, especially those contributing to NPS. The outcomes of such studies could yield vital insights into potential treatment or prevention strategies, by identifying new therapeutic targets. This could potentially lead to the development of interventions aimed at managing or preventing the onset of NPS in Alzheimer's Disease (AD) or Alzheimer's-related dementias (ADRD).